IMPROVEMENT IN TREATMENT SATISFACTION AMONG PRIMARY IMMUNODEFICIENCY PATIENTS ON AN INVESTIGATIONAL 20 % SUBCUTANEOUS IMMUNOGLOBULIN THERAPY

被引：0
|
作者：
Meckley, Lisa [1 ]
Ito, Diane [1 ]
Hu, Xingdi [1 ]
Yel, Leman [2 ]
机构：
[1] Baxalta US Inc, HEOR, Cambridge, MA USA
[2] Baxalta US Inc, Immunol, Clin Sci, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2016年 / 36卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
4335
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [41] Subcutaneous immunoglobulin use in immunoglobulin-naive patients with primary immunodeficiency: a systematic review
    Anderson-Smits, Colin
    Park, Michelle
    Bell, Judith
    Mitchell, Sarah
    Hartley, Louise
    Hawe, Emma
    IMMUNOTHERAPY, 2022, 14 (05) : 373 - 387
  • [42] Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
    Canessa, Clementina
    Iacopelli, Jessica
    Pecoraro, Antonio
    Spadaro, Giuseppe
    Matucci, Andrea
    Milito, Cinzia
    Vultaggio, Alessandra
    Agostini, Carlo
    Cinetto, Francesco
    Danieli, Maria Giovanna
    Gambini, Simona
    Marasco, Carolina
    Trizzino, Antonino
    Vacca, Angelo
    De Mattia, Domenico
    Martire, Baldassarre
    Plebani, Alessandro
    Di Gioacchino, Mario
    Gatta, Alessia
    Finocchi, Andrea
    Licciardi, Francesco
    Martino, Silvana
    De Carli, Marco
    Moschese, Viviana
    Azzari, Chiara
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2017, 30 (01) : 73 - 82
  • [43] Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
    Jolles, Stephen
    IMMUNOTARGETS AND THERAPY, 2013, 2 : 125 - 133
  • [44] Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy
    Alan P Koterba
    Mark R Stein
    Allergy, Asthma & Clinical Immunology, 10
  • [45] Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy
    Koterba, Alan P.
    Stein, Mark R.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10
  • [46] SUBCUTANEOUS IMMUNOGLOBULIN THERAPY FOR PATIENTS WITH PRIMARY IMMUNODEFICIENCY PROVIDES ECONOMIC VALUE ACROSS A WIDE RANGE OF DOSING
    Zbrozek, A.
    Hubsch, A.
    Baggish, J.
    Haddad, E.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 139 - 139
  • [47] Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency
    Richard L. Wasserman
    Isaac Melamed
    Robert P. Nelson
    Alan P. Knutsen
    Mary Beth Fasano
    Mark R. Stein
    Mikhail A. Rojavin
    Joseph A. Church
    Clinical Pharmacokinetics, 2011, 50 : 405 - 414
  • [48] Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency
    Wasserman, Richard L.
    Melamed, Isaac
    Nelson, Robert P., Jr.
    Knutsen, Alan P.
    Fasano, Mary Beth
    Stein, Mark R.
    Rojavin, Mikhail A.
    Church, Joseph A.
    CLINICAL PHARMACOKINETICS, 2011, 50 (06) : 405 - 414
  • [49] Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents
    Suez, Daniel
    Krivan, Gergely
    Jolles, Stephen
    Stein, Mark
    Gupta, Sudhir
    Paris, Kenneth
    van Hagen, P. Martin
    Brodszki, Nicholas
    Engl, Werner
    Leibl, Heinz
    McCoy, Barbara
    Yel, Leman
    IMMUNOTHERAPY, 2019, 11 (12) : 1057 - 1065
  • [50] SAFETY/TOLERABILITY OF THE NEW HUMAN SUBCUTANEOUS IMMUNOGLOBULIN (SCIG 20%) IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD)
    Paris, Kenneth
    Derfalvi, Beata
    Hussain, Iftikhar
    Haddad, Elie
    Darter, Amy
    Doralt, Jennifer
    Engl, Werner
    McCoy, Barbara
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (02) : 201 - 202
12345